SEC Form 4 · accession 0001140361-16-055232
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Williams Ph.D.
Officer — Executive Vice President
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 24, 2016 | S | 2,000 | $71.9326 | D | 40,011 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $71.9301 to $71.94, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.